Cost Analysis of Robotic Surgery Implementation

This technical report outlines the financial implications of implementing a robotic surgery program, specifically focusing on the da Vinci robotic-assisted surgery (RAS). It discusses the necessity of considering total treatment costs, which include both the initial investment and ongoing operational expenses. The report details estimated cost savings associated with various metrics, such as reduced length of hospital stays, lower rates of blood transfusions, and decreased readmission rates. It emphasizes that the da Vinci RAS can lead to significant cost reductions in complications and mortality rates. Additionally, the report presents data on system utilization trends and the impact of the da Vinci systems on surgical outcomes. The document also mentions the Genesis consultancy service, which assists hospitals in optimizing their robotic surgery programs. The report concludes by highlighting the importance of viewing robotic surgical systems as investments that can yield both clinical and financial benefits for healthcare institutions.